16/25/16 DiaMonTech AG announced that it has received ?8 million in funding from Samsung NEXT, LLC CI
26/24/26 DiaMonTech AG announced that it has received funding from Disrupt Health Impact Fund CI
07/23/07 DiaMonTech AG announced that it has received funding from Moll Family GmbH, and other investors CI
17/22/17 DiaMonTech AG announced that it has received $5 million in funding from IBB Beteiligungsgesellschaft mbH, Unorthodox Ventures, Samsung Venture Investment Corporation CI
26/19/26 DiaMonTech AG has withdrawn its IPO in the amount of €59.375 million. CI
25/19/25 DAK-Gesundheit and DiaMonTech AG Plan Strategic Cooperation in the Non-Invasive Blood Glucose Monitoring Sector for New Treatment Strategies in the Diabetes Sector CI
13/19/13 DiaMonTech AG has filed an IPO in the amount of €59.375 million. CI
11/19/11 DiaMonTech AG Signs A Further Agreement with an International Sales Company CI
21/19/21 DiaMonTech GmbH Publishes Results of Clinical Study Confirming the Accuracy of its Non-Invasive Blood Glucose-Monitoring Technology CI
01/19/01 DiaMonTech GmbH Appoints Enrico Just as Managing Director and CFO CI
16/19/16 Deutscher Apothekerverband e. V. & DiaMonTech GmbH Intends Strategic Cooperation to Significantly Improve the Care of Diabetes Patients and to Take an Innovative Step into the Future CI
09/19/09 DiaMonTech GmbH announced that it has received €7 million in funding from IBB Beteiligungsgesellschaft mbH, Bioventure Consulting GmbH, and other investors CI
05/18/05 DiaMonTech GmbH announced that it has received funding from IBB Beteiligungsgesellschaft mbH, Macnica, Inc., Jindong Investment Group Co., Ltd. CI
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer - 10/01/2015
Chief Executive Officer 52 01/04/2015
Director of Finance/CFO - 01/10/2019
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 0
-3.10%-4.19%+32.67%+59.47% 6.53TCr
+0.33%+0.33%+10.16%+78.07% 5.46TCr
+0.16%+1.73%+9.89%+102.10% 5.36TCr
-0.75%+1.38%+24.89%+50.91% 4.5TCr
-1.30%-4.80%+16.05%+114.76% 4.22TCr
+1.26%-5.26%+221.12%+900.64% 3.94TCr
-0.74%-4.46%+11.00%+44.65% 3.27TCr
-2.70%-10.77%+19.80%-6.47% 2.4TCr
+1.11%+15.18%+60.27%+49.33% 2.65TCr
Average -0.57%+1.98%+45.09%+154.83% 4.26TCr
Weighted average by Cap. -0.72%+1.72%+42.17%+153.57%
Logo DiaMonTech AG
DiaMonTech AG is a Germany-based medical device company. It develops a device for non-invasive measuring of glucose levels in diabetes patients. The device is based on spectroscopy and uses photothermal detection technology. The device range under development includes a desktop device for clinical settings and multiple users, as well as a compact pocket device for the end user.
Employees
-